secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neuronetics, Inc. (STIM)
CIK:        0001227636
Form:       8-K
Filed at:   2024-08-12T23:59:59+00:00
Accession:  0001193125-24-198417
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neuronetics to acquire Greenbrook TMS in all-stock deal; Q2 revenue down 7%, net loss widens
--------------------------------------------------------------------------------

- Q2 revenue $16.5M (-7% YoY); net loss $(9.8)M ($0.33) vs $(4.9)M ($0.17) prior year.
- Acquisition of Greenbrook TMS in all-stock deal; pro forma 2023 revenue ~$145M, double stand-alone.
- Expects at least $15M annualized cost synergies; Adjusted EBITDA positive in FY2025, cash flow positive.
- Secured $50M debt facility with Perceptive Advisors (up to $90M); repaid SLR Capital loan.
- Q3 guidance revenue $18.5M-$19.5M; FY2024 revenue $78M-$80M, opex $78M-$80M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1227636/000119312524198417/0001193125-24-198417-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1227636/000119312524198417/d760452d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-198417

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer